Phase 2
-
Nodal-Region Sparing Short-Course RT With Chemo-PD-1/Bevacizumab vs. Short-Course RT With Chemotherapy as TNT in pMMR/MSS Locally Advanced Rectal Cancer
Phase 2 · randomised · 76 people · 1 site in China · Recruiting now
-
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
Phase 2 · 20 people · 1 site in China · Recruiting now
-
Total Neoadjuvant Therapy in Rectal Cancer
Phase 2 · 42 people · 1 site in Taiwan · Recruiting now
-
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Phase 2 · 51 people · 1 site in China · Recruiting now
-
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
Phase 2 · 35 people · 1 site in China · Recruiting now
-
TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Phase 2 · 25 people · 1 site in United States · Recruiting now
-
Phase II Trial of Lung Chemoemobolization
Phase 2 · 30 people · 2 sites in United States · Recruiting now
-
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
Phase 2 · 12 people · 1 site in Germany · Recruiting now
-
SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer
Phase 2 · 30 people · 1 site in China · Recruiting now